秘密:使用合成干预的有效临床随机对照试验
1Department of Electrical and Computer Engineering, Princeton University, Princeton, 08544, NJ, USA.
Contemporary clinical trials communications
|February 14, 2024
概括
通过模拟平行组随机对照试验 (RCT) 中的交叉设计,SECRETS提高了临床试验的实力. 这种对受试者有效的方法减少了对大样本的大小的需求,提高了试验的可行性.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 药学研究 药学研究
背景情况:
- 平行组随机对照试验 (RCT) 对第三阶段的有效性至关重要,但面临的挑战是样本大小和高失败率.
- 增加试验功率的现有方法,如增强数据或使用交叉设计,在数据可比性和适用于慢性疾病方面存在局限性.
研究的目的:
- 引入SECRETS (使用合成干预的对象高效临床随机对照试验),这是一个新的框架,以增强并行组RCT的力量.
- 仅使用RCT本身的数据来模拟交叉设计的好处,从而提高对象的效率.
主要方法:
- SECRETS采用一种最先进的反事实估计算法,即合成干预 (SI),用于对所有受试者估计个别治疗效应 (ITE).
- 引入了一种新的假设测试策略,以解决SI诱导的ITE之间的依赖关系,确保可靠的治疗有效性测试.
主要成果:
- 秘密在三个现实世界的第3阶段试验中显示了RCT功率的显著增加,平均增加21.5%.
- 该框架将所需的样本大小减少了平均每臂2000个受试者,以达到80%的功率和5%的显著性.
- 分析证实,SECRETS始终降低了平均治疗效果的差异,有效地模仿了交叉设计的好处.
结论:
- SECRETS为增加临床试验功率提供了一个可行的解决方案,特别是当满足样本大小要求具有挑战性时.
- 通过模拟交叉设计,SECRETS提高了并行组RCT中的受试者效率,使其更加实用和有效.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
480
相关概念视频
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122
